Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy

QR Code

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy

Amy Fleischman, Erinn T RhodesDivision of Endocrinology, Children&rsquo;s Hospital Boston, Boston, MA, United StatesAbstract: Childhood obesity has become a national and international epidemic. The prevalence and incidence of type 2 diabetes in youth have been increasing, and type 2 diabetes...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Amy Fleischman, Erinn T Rhodes
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2009
Sujets:	Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/4c445ceff3d74d0095b2d530d1c4439c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Insulin detemir for the treatment of obese patients with type 2 diabetes
par: Hollander PA
Publié: (2012)

Insulin glulisine in the management of diabetes
par: Satoru Yamada
Publié: (2009)

Adipose inflammation: cause or consequence of obesity-related insulin resistance
par: Haiyan Xu, et autres
Publié: (2008)

Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes
par: Thuillier P, et autres
Publié: (2015)

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
par: Wondmkun YT
Publié: (2020)

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
par: Gregory E Peterson
Publié: (2009)

Linking obesity with type 2 diabetes: the role of T-bet
par: Wali JA, et autres
Publié: (2014)

Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
par: Mackenzie RWA, et autres
Publié: (2014)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
par: Stanley S Schwartz
Publié: (2010)

Management of diabetes across the course of disease: minimizing obesity-associated complications
par: Apovian CM
Publié: (2011)

Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
par: Paul Valensi
Publié: (2009)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
par: Wilke T, et autres
Publié: (2019)

Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
par: Dara P Schuster
Publié: (2010)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
par: Jean-Pierre Le Floch
Publié: (2010)

ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with Insulin Resistance in Obesity [Corrigendum]
par: Vincent V, et autres
Publié: (2019)

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
par: Bradley Curtis, et autres
Publié: (2008)

Type 2 diabetes in Brazil: epidemiology and management
par: Almeida-Pititto B, et autres
Publié: (2015)

Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
par: Duckett SK, et autres
Publié: (2014)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
par: Shitalkumar P Zambad, et autres
Publié: (2011)

Risk management in the treatment of type 2 diabetes with pioglitazone
par: Giuseppe Derosa, et autres
Publié: (2009)

SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
par: Seufert J
Publié: (2015)

Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England
par: Stephen CL Gough, et autres
Publié: (2009)

Mechanism linking diabetes mellitus and obesity
par: Al-Goblan AS, et autres
Publié: (2014)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
par: Robert Moses
Publié: (2009)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
par: Joshua J Neumiller, et autres
Publié: (2010)

Relationship between insulin resistance and plasma vitamin D in adults
par: Badawi A, et autres
Publié: (2014)

Evaluation of the relationship between the pelvic floor muscles and insulin resistance
par: Micussi MT, et autres
Publié: (2015)

C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese
par: Dongway AC, et autres
Publié: (2015)

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
par: Kostev K, et autres
Publié: (2015)

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
par: Colosia AD, et autres
Publié: (2013)

Circulating miRNA Signatures Associated with Insulin Resistance in Adolescents with Obesity
par: Lin H, et autres
Publié: (2020)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
par: Anderson M, et autres
Publié: (2014)

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
par: Berlie H, et autres
Publié: (2012)

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
par: Baptist Gallwitz
Publié: (2010)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
par: AlMaatouq MA
Publié: (2012)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
par: Lorber D
Publié: (2014)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
par: Al Sifri S
Publié: (2012)

Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome
par: Smith CJ, et autres
Publié: (2015)

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
par: Kim Y, et autres
Publié: (2012)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
par: Ofori SN, et autres
Publié: (2014)